Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Surface plasmon resonance biosensors have become the go-to technology for drug discovery in the pharmaceutical and biotechnology sectors, offering label-free, real-time measurements that characterize the interactions of nearly any molecular system. Carterra is a leader in high throughput biology solutions, and the company’s LSA® platform combines patented microfluidics technology with real-time high throughput surface plasmon resonance to enable 100 times higher throughput for monoclonal antibody screening and characterization.